By using this site, you agree to the Privacy Policy and Terms Of Use.
Accept
WhatsNew2DayWhatsNew2Day
  • Home
  • Australia
  • Business
  • Economy
  • Entertainment
  • Gaming
  • Health
  • Lifestyle
  • Science
  • Sports
  • Tech
  • US
  • World
Reading: Makena, a drug designed to prevent premature births, will be withdrawn from the market after studies indicate that it does not work
Share
Aa
WhatsNew2DayWhatsNew2Day
Aa
  • Home
  • Contact
  • About us
  • Privacy Policy
  • Home
  • Australia
  • Business
  • Economy
  • Entertainment
  • Gaming
  • Health
  • Lifestyle
  • Science
  • Sports
  • Tech
  • US
  • World
Follow US
© 2022 WhatsNew2Day News Network. All Rights Reserved.
WhatsNew2Day > News > Makena, a drug designed to prevent premature births, will be withdrawn from the market after studies indicate that it does not work
News

Makena, a drug designed to prevent premature births, will be withdrawn from the market after studies indicate that it does not work

Last updated: 2023/03/08 at 5:05 PM
Jacky 2 weeks ago
Share
This image provided by Covis Pharma shows the packaging of the company's Makena drug.
SHARE

After years of disputes with the US Federal Drug Administration (FDA), the maker of a drug that is supposed to prevent premature birth but apparently doesn’t, is voluntarily withdrawing it from the market .

Manufacturer Covis Pharma opted to pull the drug, Makena, from shelves after the FDA indicated it was taking steps to remove it from the market anyway. Plans to do so have been delayed for more than 12 years as Covis tried to prove the drug effective but couldn’t.

“While we maintain Makena’s favorable risk-benefit profile, including its efficacy in women at increased risk of preterm birth, we seek to voluntarily withdraw the product and work with the FDA to effect an orderly liquidation,” said Covis’ chief innovation officer. raghavchari said in a statement.

“We appreciate the attention the agency has directed to this issue, particularly given the complexity of withdrawing a drug with mixed efficacy data and a positive safety profile, and welcome the opportunity to discuss an appropriate phase-down plan for patients,” he added. .

This image provided by Covis Pharma shows the packaging of the company’s Makena drug. (AP)

Makena is a synthetic version of progesterone, a hormone needed to maintain a pregnancy, and has been the only drug approved by the FDA to reduce the risk of giving birth prematurely. Administered in weekly injections starting at 16 weeks of pregnancy, it is intended for women who have given birth prematurely.

The FDA’s initial accelerated approval came in 2011 after a 500-person study indicated the drug helped women who had given birth early, with the caveat that Covis had to do more research to confirm that the drug helped. medication helped create healthier babies.

In 2019, another study, this one of 1,700 people, failed to show a reduction in preterm births or a healthier infant outcome. Last October, a board of external FDA advisors voted to recommend withdrawing the agency’s approval.

The FDA still plans to continue with its own process to recall it despite the Covis announcement. The final decision will be made by FDA Commissioner Robert Califf, with input from the agency’s chief scientist.

Some groups, including the American College of Obstetricians and Gynecologists, had urged the FDA to keep the drug in circulation pending further investigation. The organization had no comment Wednesday.

About 10% of births occur before 37 weeks gestation, which can lead to serious health problems and possible death. There is a higher rate of premature birth among black women.

with cable news services

Source link

You Might Also Like

Martina Navratilova says she is cancer-free, months after revealing breast and throat cancer diagnosis

Mask Mandate on Public Transport Ends Next Week

The simple health test that could save your life

7 Virginia sheriffs deputies arrested in death of suspect

New York City Council President Adams backs concept of reducing the size and scope of the NYPD, a key progressive promise

TAGGED: births, Designed, Drug, Makena, market, premature, prevent, Studies, withdrawn, work
Jacky March 8, 2023
Share this Article
Facebook Twitter Email Print
Share
Previous Article Netball Australia is still in debt after Gina Rinehart (pictured) pulled a massive $15m endorsement deal Netball Australia sponsorship saga: Sport in debt after Gina Rinehart backs out of $15m deal
Next Article Lawyers make opening statements in Mark Ridley-Thomas corruption trial Lawyers make opening statements in Mark Ridley-Thomas corruption trial

Latest

Martina Navratilova at the All England Tennis Club in Wimbledon, southwest London, on July 6, 2019.
Martina Navratilova says she is cancer-free, months after revealing breast and throat cancer diagnosis
News
DC-W 130/3 (16.1 ov, Alice Capsey 34*, Marizanne Kapp 24*, Deepti Sharma 0/31) - Live - UP Warriorz Women vs Delhi Capitals Women, Women's Premier League 2023 2023, 20th Match Match Score live, summary |  ESPN.in
DC-W 130/3 (16.1 ov, Alice Capsey 34*, Marizanne Kapp 24*, Deepti Sharma 0/31) – Live – UP Warriorz Women vs Delhi Capitals Women, Women’s Premier League 2023 2023, 20th Match Match Score live, summary | ESPN.in
Sports
Pokémon Go ‘Let’s Go’ event, Collection Challenge guide
Pokémon Go ‘Let’s Go’ event, Collection Challenge guide
Gaming
Mask Mandate on Public Transport Ends Next Week
Mask Mandate on Public Transport Ends Next Week
News
The simple health test that could save your life
The simple health test that could save your life
News
7 Virginia sheriffs deputies arrested in death of suspect
7 Virginia sheriffs deputies arrested in death of suspect
News

nba 2k23 mt

© WhatsNew2Day News Network. All Rights Reserved. Email: contact@whatsnew2day.com

  • Home
  • Contact
  • About us
  • Privacy Policy

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?